Madison, WI, United States of America

Cara Rieger

This inventor holds 1 USPTO granted patent. Top assignees: Fujifilm Cellular Dynamics, Inc., Fujifilm Holdings America Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cara Rieger. Retrieved from https://idiyas.com/inventor/cara-rieger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Cara Rieger

Introduction

Cara Rieger is an accomplished inventor based in Madison, WI (US). She has made significant strides in the field of cardiac research, particularly in the production of cardiac fibroblasts. Her work has the potential to impact regenerative medicine and heart disease treatment.

Latest Patents

Cara Rieger holds a patent titled "Methods for the production of cardiac fibroblasts." This patent outlines methods for producing quiescent cardiac fibroblast cells from pluripotent stem cells. Additionally, it includes microtissue compositions that comprise cardiac fibroblast cells along with endothelial cells and cardiomyocytes. This innovative approach could lead to advancements in cardiac therapies.

Career Highlights

Throughout her career, Cara has worked with notable companies such as Fujifilm Cellular Dynamics, Inc. and Fujifilm Holdings America Corporation. Her experience in these organizations has contributed to her expertise in cellular dynamics and regenerative medicine.

Collaborations

Cara has collaborated with various professionals in her field, including her coworker Sarah Himmerich. Their joint efforts have furthered research and development in cardiac health.

Conclusion

Cara Rieger's contributions to the field of cardiac fibroblast production exemplify her innovative spirit and dedication to advancing medical science. Her work continues to inspire future research and development in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…